T1	KeyEntity 161 184;200 204	Tripeptidyl-peptidase I CLN2
T2	Entity 235 274	sedolisins (serine-carboxyl peptidases)
T3	Entity 367 422	classical late-infantile neuronal ceroid lipofuscinosis
T4	Entity 663 672;676 686	orthologs human CLN2
T10	Entity 1026 1036	human CLN2
T11	Entity 1081 1110	Pseudomonas sp. 101 sedolisin
T12	Entity 1125 1129	CLN2
T13	Entity 1241 1252	life cycles
T14	Entity 1380 1392	CLN2 enzymes
T15	Entity 1434 1446	tripeptidase
T16	Entity 1672 1676	CLN2
T17	Entity 1658 1668	inhibitors
T18	KeyEntity 11 41	tripeptidyl-peptidase I (CLN2)
T19	Entity 91 107	sedolisin family
T20	Entity 111 137	serine-carboxyl peptidases
T22	KeyEntity 2006 2010	CLN2
T23	KeyEntity 2305 2309	CLN2
T24	KeyEntity 2454 2458	CLN2
T25	KeyEntity 2634 2638	CLN2
T26	KeyEntity 3159 3163	CLN2
T27	KeyEntity 3303 3307	CLN2
T28	KeyEntity 4091 4095	CLN2
T31	Entity 4621 4625;4678 4683;4685 4692;4694 4697;4699 4704;4706 4709;4715 4718	CLN2 human macaque dog mouse rat cow
T39	KeyEntity 7629 7633	CLN2
T40	Entity 7668 7672;7678 7683;7685 7689;7695 7704	CLN2 human fugu zebrafish
T41	Entity 7753 7757;7761 7779	CLN2 Xenopus tropicalis
T42	KeyEntity 7926 7930	CLN2
T43	KeyEntity 8430 8440	human CLN2
T44	KeyEntity 8614 8618	CLN2
T46	KeyEntity 8960 8970	human CLN2
T47	KeyEntity 8998 9002	CLN2
T48	KeyEntity 9447 9451	CLN2
T51	KeyEntity 10082 10086	CLN2
T52	KeyEntity 10297 10301	CLN2
T54	KeyEntity 10754 10758	CLN2
T55	KeyEntity 11242 11246	CLN2
T56	KeyEntity 11401 11405	CLN2
T58	KeyEntity 11550 11554	CLN2
T59	KeyEntity 11928 11932	CLN2
T60	KeyEntity 11986 11990	CLN2
T63	KeyEntity 14299 14303	CLN2
T64	KeyEntity 14576 14580	CLN2
T65	KeyEntity 14770 14774	CLN2
T66	KeyEntity 14955 14959	CLN2
T67	KeyEntity 15277 15281	CLN2
T68	KeyEntity 15473 15477	CLN2
T69	KeyEntity 15850 15854	CLN2
T70	KeyEntity 16063 16067	CLN2
T71	KeyEntity 16378 16382	CLN2
T73	KeyEntity 17556 17560	CLN2
T74	Entity 17780 17784	CLN2
T75	KeyEntity 18076 18080	CLN2
T76	KeyEntity 18199 18203	CLN2
T77	KeyEntity 18276 18280	CLN2
T78	KeyEntity 18352 18356	CLN2
T79	KeyEntity 18881 18885	CLN2
T80	KeyEntity 19032 19036	CLN2
T81	KeyEntity 19335 19339	CLN2
T82	KeyEntity 19799 19803	CLN2
T83	KeyEntity 20027 20031	CLN2
T84	KeyEntity 20180 20184	CLN2
T85	KeyEntity 20623 20627	CLN2
T86	KeyEntity 20780 20784	CLN2
T88	KeyEntity 21089 21093	CLN2
T89	KeyEntity 21799 21803	CLN2
T90	KeyEntity 22114 22118	CLN2
T91	KeyEntity 22214 22218	CLN2
T94	KeyEntity 24322 24326	CLN2
T95	KeyEntity 26668 26672	CLN2
T96	KeyEntity 1717 1748	tripeptidyl-peptidase I (TPP-I)
T97	KeyEntity 1940 1945	TPP-I
R1	other_relation Arg1:T97 Arg2:T22	
#1	AnnotatorNotes R1	synonyms
T98	Entity 2042 2051;2104 2108	mutations CLN2
T99	Entity 2136 2177	fatal inherited neurodegenerative disease
T100	Entity 2179 2234	classical late-infantile neuronal ceroid lipofuscinosis
R2	is_subclass_of Arg1:T100 Arg2:T99	
R3	other_relation Arg1:T98 Arg2:T100	
#2	AnnotatorNotes R3	causes
T101	Entity 2315 2331	serine peptidase
R4	is_subclass_of Arg1:T23 Arg2:T101	
T102	Entity 2411 2425	catalytic site
T103	Entity 2536 2570	high-resolution crystal structures
T104	Entity 2578 2595	bacterial enzymes
T105	Entity 2640 2649	sedolisin
T106	Entity 2654 2665	kumamolisin
R5	is_subclass_of Arg1:T105 Arg2:T104	
R6	is_subclass_of Arg1:T106 Arg2:T104	
T107	Entity 2754 2764	sedolisins
T108	Entity 2768 2794	serine-carboxyl peptidases
R7	other_relation Arg1:T107 Arg2:T108	
#3	AnnotatorNotes R7	synonyms
T109	Entity 2858 2889	catalytic triad (Ser, Glu, Asp)
T110	Entity 2916 2919	Asp
T111	Entity 2927 2940	oxyanion hole
R8	is_part_of Arg1:T110 Arg2:T111	
T112	Entity 2946 2955	Sedolisin
T113	Entity 2988 2999	kumamolisin
T114	Entity 3001 3007	aorsin
T115	Entity 3017 3029	physarolisin
T116	Entity 3059 3066	archaea
T117	Entity 3068 3076	bacteria
T118	Entity 3078 3083	fungi
T119	Entity 3088 3095	amoebae
T120	Entity 3195 3205	sedolisins
T121	Entity 6984 6997	sedolisin-TPP
T122	Entity 6954 6970	fugu CLN2 analog
R9	other_relation Arg1:T121 Arg2:T122	
#4	AnnotatorNotes R9	synonyms
T123	Entity 7209 7223;7231 7248	amino terminus propeptide region
T124	Entity 7551 7577	fugu sequencing consortium
T125	Entity 7591 7600;7608 7625	Sequences catalytic domains
T126	Entity 8067 8091	sedolisin-TPP (AL594774)
T127	Entity 8105 8117	EST database
T128	Entity 8148 8164	catalytic domain
T129	Entity 8225 8235	N terminus
T130	Entity 8254 8262;8276 8281	aspartic acids
T131	Entity 8267 8281	glutamic acids
T132	Entity 8301 8316	catalytic triad
R10	is_part_of Arg1:T130 Arg2:T132	
R11	is_part_of Arg1:T131 Arg2:T132	
T133	Entity 8388 8406	fugu sedolisin-TPP
T134	Entity 8476 8485;8496 8506	bacterial sedolisins
T135	Entity 8489 8506	fungal sedolisins
T45	Entity 8648 8682	highly conserved CLN2-like enzymes
T136	Entity 8773 8783	peptidases
T137	Entity 8931 8939;8947 8956	Modeling structure
T138	Entity 9453 9462	sedolisin
T139	Entity 9468 9479	kumamolisin
T140	Entity 9701 9710	sedolisin
T141	Entity 10423 10432	sedolisin
T142	Entity 10530 10539	sedolisin
T143	Entity 10541 10552	kumamolisin
T53	KeyEntity 10558 10568	human CLN2
T145	Entity 10888 10897	sedolisin
T146	Entity 10902 10913	kumamolisin
T147	Entity 11630 11639	sedolisin
T148	Entity 11644 11655	kumamolisin
T149	Entity 11937 11946	sedolisin
T150	Entity 12307 12316	sedolisin
T151	Entity 12320 12331	kumamolisin
T152	Entity 13631 13640	sedolisin
T153	Entity 13963 13972	sedolisin
T154	Entity 13977 13988	kumamolisin
T155	Entity 14193 14202	sedolisin
T156	Entity 14486 14495	sedolisin
T157	Entity 14713 14722	sedolisin
T158	Entity 14906 14915	sedolisin
T159	Entity 15587 15596	sedolisin
T160	Entity 15600 15611	kumamolisin
T161	Entity 20647 20658	kumamolisin
T162	Entity 20669 20678	sedolisin
T163	Entity 20898 20907	sedolisin
T164	Entity 20909 20920	kumamolisin
T165	Entity 21875 21884	sedolisin
T166	Entity 21888 21899	kumamolisin
T167	Entity 22279 22288	sedolisin
T168	Entity 22293 22304	kumamolisin
T169	Entity 22467 22502	sedolisin/serine-carboxyl peptidase
T170	Entity 22671 22680	sedolisin
T171	Entity 22685 22696	kumamolisin
T172	Entity 22811 22820	sedolisin
T173	Entity 23175 23184	sedolisin
T174	Entity 23186 23197	kumamolisin
T92	KeyEntity 23207 23217	human CLN2
T175	Entity 23636 23645	sedolisin
T178	Entity 23651 23662	kumamolisin
T179	Entity 23781 23790	sedolisin
T180	Entity 23795 23806	kumamolisin
T30	KeyEntity 4342 4352	human CLN2
T181	Entity 24075 24084	sedolisin
T93	KeyEntity 24031 24041	human CLN2
T62	KeyEntity 13536 13546	human CLN2
T61	KeyEntity 12719 12729	human CLN2
T57	KeyEntity 11504 11514	human CLN2
T50	KeyEntity 9840 9850	human CLN2
T49	KeyEntity 9615 9625	human CLN2
T182	Entity 3453 3468;3477 3483	crystallization enzyme
T183	Entity 3506 3528	experimental structure
T184	Entity 3541 3556	crystallography
T185	Entity 3560 3563	NMR
T186	Entity 3603 3621	molecular modeling
T187	Entity 3770 3780	inhibitors
T188	Entity 3826 3834	modeling
T189	Entity 3859 3871	HIV protease
T190	Entity 3902 3911	peptidase
T191	Entity 3919 3930	coronavirus
T192	Entity 3947 3980	severe acute respiratory syndrome
T193	Entity 4379 4389	sedolisins
T194	Entity 4207 4213;4226 4236	design inhibitors
T29	Entity 4291 4308	CLN2-like enzymes
R12	is_subclass_of Arg1:T19 Arg2:T20	
T38	Entity 334 365	fatal neurodegenerative disease
R13	is_subclass_of Arg1:T3 Arg2:T38	
T5	Entity 1525 1541	structural model
T6	Entity 4034 4061	molecular homology modeling
T7	Entity 4065 4075;4078 4087	predicting structure
T8	Entity 4559 4582	active catalytic domain
T9	Entity 4831 4841	prosegment
T21	Entity 4850 4866	catalytic domain
T32	Entity 4890 4900	mouse CLN2
T195	Entity 4912 4927;4935 4945	single deletion prosegment
R14	other_relation Arg1:T195 Arg2:T32	
#5	AnnotatorNotes R14	is a characteristic of
T196	Entity 5271 5294	highly conserved enzyme
T33	Entity 5240 5254	mammalian CLN2
T34	Entity 5331 5358	mammalian CLN2-like enzymes
T197	Entity 5425 5435	prosegment
T198	Entity 5458 5469	active site
T199	Entity 5753 5778	maturation cleavage point
T200	Entity 5794 5804;5812 5825	N terminus active enzyme
T35	Entity 5887 5904	CLN2-like enzymes
T36	Entity 6280 6289	fugu CLN2
T37	Entity 6711 6725	zebrafish CLN2
T201	Entity 7877 7897	Active site residues
T202	Entity 9060 9076	protein modeling
T203	Entity 9093 9098	model
T204	Entity 9344 9368	water-soluble sedolisins
T205	Entity 9375 9380	model
T206	Entity 9589 9611	homology-derived model
T207	Entity 9652 9666	homology model
T208	Entity 9718 9744	covalently-bound inhibitor
T209	Entity 9746 9767	pseudo-iodotyrostatin
R15	is_subclass_of Arg1:T209 Arg2:T208	
T210	Entity 9883 9905;9915 9926	aldehyde functionality "C-termini"
T211	Entity 9953 9963	inhibitors
T212	Entity 10022 10043	pseudo-iodotyrostatin
T213	Entity 10057 10066	inhibitor
T214	Entity 10137 10146	inhibitor
T215	Entity 10183 10188	model
T216	Entity 10245 10253;10259 10288	modeling pseudo-iodotyrostatin complex
T217	Entity 10307 10319	tripeptidase
R16	is_subclass_of Arg1:T52 Arg2:T217	
T218	Entity 10335 10344	inhibitor
T219	Entity 10368 10390	experimental structure
T220	Entity 10396 10413	tripeptide analog
R17	interacts_with Arg1:T220 Arg2:T141	
R18	interacts_with Arg1:T209 Arg2:T140	
T221	Entity 10445 10463	Sequence alignment
T222	Entity 10467 10476;10491 10498	bacterial enzymes
T223	Entity 10481 10498	mammalian enzymes
T224	Entity 10500 10509;10517 10526	Alignment sequences
T225	Entity 10581 10593;10601 10606	construction model
T226	Entity 10778 10800;10804 10813	experimental structure sedolisin
T144	Entity 10968 10973	model
T227	Entity 11020 11034	disulfide bond
T228	Entity 10934 10940;10952 10960	Cys327 residues
T229	Entity 10945 10960	Cys342 residues
R19	is_part_of Arg1:T228 Arg2:T144	
R20	is_part_of Arg1:T229 Arg2:T144	
T230	Entity 11178 11187	cysteines
T231	Entity 11317 11337	bacterial sedolisins
T232	Entity 11353 11362	disulfide
T233	Entity 11478 11500	homology-derived model
T234	Entity 11516 11530	Ribbon diagram
T235	Entity 11538 11546	Cα trace
T236	Entity 10723 10737	Cα coordinates
T237	Entity 11605 11626	highly conserved core
R21	is_part_of Arg1:T237 Arg2:T147	
R22	is_part_of Arg1:T237 Arg2:T148	
T238	Entity 11798 11843	late-infantile neuronal ceroid lipofuscinosis
T239	Entity 11899 11924	substrate binding pockets
T240	Entity 12004 12016	tripeptidase
R23	is_subclass_of Arg1:T60 Arg2:T240	
T241	Entity 12044 12069	substrate-binding pockets
T242	Entity 12185 12194	inhibitor
T243	Entity 12337 12347	inhibitors
T244	Entity 12365 12373	tyrosine
T245	Entity 12379 12392	phenylalanine
T246	Entity 12407 12416	S1 pocket
T247	Entity 12071 12073	S1
T248	Entity 12082 12084	S3
T249	Entity 12475 12485	sedolisins
T250	Entity 12838 12844	Thr279
T251	Entity 12877 12883	SGTSAS
T252	Entity 12900 12916	catalytic Ser280
T253	Entity 12959 12965	Asp165
T254	Entity 13037 13050	oxyanion hole
R24	is_part_of Arg1:T253 Arg2:T254	
T255	Entity 13102 13111	S1 pocket
T256	Entity 13237 13251	steric barrier
T257	Entity 13256 13273	excluding solvent
T258	Entity 13376 13382	Gly131
R25	is_subclass_of Arg1:T247 Arg2:T241	
R26	is_subclass_of Arg1:T248 Arg2:T241	
T259	Entity 13508 13513;13521 13532	model active site
T260	Entity 13584 13605	pseudo-iodotyrostatin
R27	interacts_with Arg1:T260 Arg2:T152	
T261	Entity 13651 13661	peptidases
R28	is_subclass_of Arg1:T152 Arg2:T261	
T262	Entity 13799 13808	inhibitor
T263	Entity 13780 13791	stick model
T264	Entity 14142 14148	Asp179
T265	Entity 14152 14163	kumamolisin
T266	Entity 14183 14189	Ser190
R29	is_part_of Arg1:T264 Arg2:T265	
R30	is_part_of Arg1:T266 Arg2:T155	
T267	Entity 14230 14241	P1 tyrosine
T268	Entity 14249 14258	inhibitor
R31	is_part_of Arg1:T267 Arg2:T268	
R32	interacts_with Arg1:T264 Arg2:T267	
R33	interacts_with Arg1:T266 Arg2:T267	
T269	Entity 14307 14313	Thr182
T270	Entity 14422 14433	P1 tyrosine
T271	Entity 14441 14455	polar residues
T272	Entity 14476 14482	Glu175
R34	is_subclass_of Arg1:T272 Arg2:T271	
R35	is_part_of Arg1:T272 Arg2:T156	
T273	Entity 14518 14524	Asp169
T274	Entity 14528 14539	kumamolisin
R36	is_part_of Arg1:T273 Arg2:T274	
R37	is_subclass_of Arg1:T273 Arg2:T271	
T275	Entity 14584 14590	Cys170
T276	Entity 14692 14698	Glu175
T277	Entity 14703 14709	Glu171
R38	interacts_with Arg1:T276 Arg2:T277	
T278	Entity 14778 14784	Ser166
T279	Entity 14835 14844	S1 pocket
T280	Entity 14896 14902	Arg179
R39	is_part_of Arg1:T280 Arg2:T158	
T281	Entity 14945 14951	Ser174
R40	is_part_of Arg1:T281 Arg2:T66	
T282	Entity 15158 15169	kumamolisin
T283	Entity 15264 15273	S1 pocket
T284	Entity 15460 15469	S2 pocket
T285	Entity 15515 15522	solvent
T286	Entity 15640 15645	Trp81
T287	Entity 15664 15670	Trp129
R41	is_part_of Arg1:T286 Arg2:T159	
R42	is_part_of Arg1:T287 Arg2:T160	
T288	Entity 15803 15809	Tyr130
R43	is_part_of Arg1:T288 Arg2:T69	
T289	Entity 15905 15915	P2 residue
T290	Entity 16040 16059	predicted structure
T291	Entity 16111 16120	S3 pocket
T292	Entity 16144 16156	tripeptidase
R44	is_subclass_of Arg1:T70 Arg2:T292	
T293	Entity 16202 16215	P3 side chain
T294	Entity 16321 16337	N-terminal amine
T295	Entity 16417 16423	Asp132
R45	is_part_of Arg1:T295 Arg2:T71	
T296	Entity 16480 16491	carboxylate
T297	Entity 16449 16454	model
T298	Entity 16500 16508;16516 16526	nitrogen N-terminus
T299	Entity 16605 16621	hydrogen-bonding
T300	Entity 16749 16762	hydrogen bond
T301	Entity 16771 16777	Asp132
T302	Entity 16782 16788	Ser139
R46	interacts_with Arg1:T301 Arg2:T302	
T72	Entity 16916 16933	CLN2-like enzymes
T303	Entity 16948 16957	mutations
T304	Entity 16993 17002	mutations
T305	Entity 17019 17033	genetic survey
T306	Entity 17049 17102	classic late-infantile neuronal ceroid lipofuscinosis
T307	Entity 14403 14416	hydrogen bond
T308	Entity 17158 17167	mutations
T309	Entity 17199 17215	truncated enzyme
T310	Entity 17222 17251	incorrect intron-exon splices
T311	Entity 17274 17283	mutations
T312	Entity 17292 17323	single amino acid substitutions
T313	Entity 17351 17360	mutations
T314	Entity 17369 17373	I92N
T315	Entity 17375 17380	E148K
T316	Entity 17382 17387	C170R
T317	Entity 17392 17397	C170Y
T318	Entity 17399 17404	V190D
T319	Entity 17406 17411	G194E
T320	Entity 17413 17418	Q227H
T321	Entity 17420 17425	R252H
T322	Entity 17427 17432	A259E
T323	Entity 17438 17443	S280L
R47	is_subclass_of Arg1:T314 Arg2:T313	
R48	is_subclass_of Arg1:T315 Arg2:T313	
R49	is_subclass_of Arg1:T316 Arg2:T313	
R50	is_subclass_of Arg1:T317 Arg2:T313	
R51	is_subclass_of Arg1:T318 Arg2:T313	
R52	is_subclass_of Arg1:T319 Arg2:T313	
R53	is_subclass_of Arg1:T320 Arg2:T313	
R54	is_subclass_of Arg1:T321 Arg2:T313	
R55	is_subclass_of Arg1:T322 Arg2:T313	
R56	is_subclass_of Arg1:T323 Arg2:T313	
T324	Entity 17484 17492	mutation
T325	Entity 17536 17552	catalytic serine
R57	is_part_of Arg1:T325 Arg2:T73	
T326	Entity 17603 17621	enzymatic activity
T327	Entity 17715 17721	Val190
T328	Entity 17723 17729	Gly194
T329	Entity 17735 17741	Arg252
T330	Entity 17803 17813	sedolisins
T331	Entity 17888 17897	mutations
T332	Entity 17916 17920;17924 17942	loss enzymatic activity
T333	Entity 17999 18008	mutations
T334	Entity 18170 18180	Substrates
T335	Entity 18185 18195	inhibitors
T336	Entity 18262 18272	substrates
T337	Entity 18290 18297	defects
T338	Entity 18311 18322	truncations
T339	Entity 18327 18348	single-site mutations
R58	is_subclass_of Arg1:T338 Arg2:T337	
R59	is_subclass_of Arg1:T339 Arg2:T337	
T340	Entity 18423 18468	late-infantile neuronal ceroid lipofuscinosis
T341	Entity 18517 18529;18536 18579	accumulation autofluorescent material, ceroid-lipofuscin
T342	Entity 18584 18608	lysosomal storage bodies
T343	Entity 18649 18663	nervous system
T344	Entity 18725 18734	subunit c
T345	Entity 18738 18764	mitochondrial ATP synthase
R60	is_part_of Arg1:T344 Arg2:T345	
T346	Entity 18839 18847	protease
T347	Entity 18925 18935	N terminus
T348	Entity 19084 19112	angiotensin-derived peptides
R61	interacts_with Arg1:T80 Arg2:T348	
T349	Entity 19270 19292	tripeptide Asp-Arg-Val
T350	Entity 19310 19320	N terminus
R62	is_part_of Arg1:T349 Arg2:T350	
T351	Entity 19412 19434	substrate-binding site
T352	Entity 19570 19580;19588 19598	acetylated N terminus
R63	is_part_of Arg1:T351 Arg2:T81	
T353	Entity 19671 19693	N-terminal amino group
T354	Entity 19717 19723	Asp132
T355	Entity 19771 19783	tripeptidase
R64	is_subclass_of Arg1:T82 Arg2:T355	
R65	interacts_with Arg1:T354 Arg2:T353	
T356	Entity 19827 19838	tripeptides
T357	Entity 19870 19878	glucagon
T358	Entity 19997 20019	substrate-binding site
R66	is_part_of Arg1:T358 Arg2:T83	
T359	Entity 20098 20113	cholecystokinin
T360	Entity 20133 20146	neuropeptides
T361	Entity 20212 20244	cleave collagen-related peptides
R67	participates_in Arg1:T84 Arg2:T361	
T362	Entity 20384 20395	kumamolisin
T363	Entity 20475 20489	kumamolisin-As
T364	Entity 20523 20548	collagen-related peptides
T365	Entity 20559 20581	native type I collagen
R68	interacts_with Arg1:T362 Arg2:T364	
R69	interacts_with Arg1:T363 Arg2:T364	
R70	interacts_with Arg1:T362 Arg2:T365	
R71	interacts_with Arg1:T363 Arg2:T365	
T366	Entity 20597 20619	substrate-binding site
R72	is_part_of Arg1:T366 Arg2:T85	
T367	Entity 20715 20735	collagenase activity
R73	participates_in Arg1:T161 Arg2:T367	
T368	Entity 20752 20771	collagen-processing
T369	Entity 20846 20865;20869 20873	catalytic machinery CLN2
T87	Entity 20957 20983	serine-carboxyl peptidases
R74	is_subclass_of Arg1:T163 Arg2:T87	
R75	is_subclass_of Arg1:T164 Arg2:T87	
T370	Entity 21065 21075	inhibitors
T371	Entity 21217 21239	aldehyde functionality
T372	Entity 21258 21279;21289 21305	covalent interactions catalytic serine
R76	interacts_with Arg1:T371 Arg2:T372	
T373	Entity 21329 21348	chloromethyl ketone
R77	interacts_with Arg1:T373 Arg2:T372	
T374	Entity 21385 21395	inhibitors
T375	Entity 21447 21457	sedolisins
T376	Entity 21481 21492	tripeptides
T377	Entity 21504 21519;21529 21538	blocking groups N termini
T378	Entity 21544 21571;21577 21591	tripeptide-based inhibitors free N termini
T379	Entity 21992 22022	experimental crystal structure
T380	Entity 22047 22057	inhibitors
T381	Entity 21834 21844	S1 subsite
T382	Entity 21929 21937	P1 group
R78	is_part_of Arg1:T381 Arg2:T89	
T383	Entity 22153 22170	Homology modeling
T384	Entity 22172 22210	Three-dimensional, atomic-scale models
T385	Entity 22759 22777	sequence alignment
T386	Entity 23020 23048	pair-wise sequence alignment
T387	Entity 23310 23329	sequence alignments
T388	Entity 23505 23517;23525 23534;23539 23550	core regions sedolisin kumamolisin
T176	Entity 23931 23943	core regions
T177	Entity 24104 24113	inhibitor
T389	Entity 24114 24131	pseudo-tyrostatin
R79	is_subclass_of Arg1:T389 Arg2:T177	
T390	Entity 24204 24218	protein models
T391	Entity 24257 24266	inhibitor
T392	Entity 24296 24308	tripeptidase
R80	is_subclass_of Arg1:T94 Arg2:T392	
T393	Entity 24491 24508	homology modeling
T394	Entity 24596 24600	core
T395	Entity 24605 24616	active site
T396	Entity 25100 25110	insertions
T397	Entity 25115 25124	deletions
T398	Entity 25407 25421	homology model
T399	Entity 25494 25505	active site
T400	Entity 25513 25518	model
T401	Entity 25644 25649	model
T402	Entity 25655 25660	model
T403	Entity 25688 25716	energy minimization in vacuo
T404	Entity 25799 25816	covalent geometry
T405	Entity 25821 25844	non-bonded interactions
T406	Entity 25950 25962	bond lengths
T407	Entity 25964 25978	3-point angles
T408	Entity 25983 26006	4-point dihedral angles
T409	Entity 26019 26045	eliminating atomic overlap
T410	Entity 26058 26070	salt-bridges
T411	Entity 26075 26089	hydrogen bonds
T412	Entity 26621 26629;26637 26664	modeling three-dimensional structure
T413	Entity 26690 26695	model
T414	Entity 26719 26737;26741 26751	crystal structures sedolisins
T415	Entity 26820 26846	serine-carboxyl peptidases
T416	Entity 26871 26881	inhibitors
